To analyze how the use of metabolic and bariatric surgery trends correlate with the increasing use of GLP-1 receptor agonists through 2025.
Conducted a cross-sectional analysis of surgery use trends.
Collected data on metabolic and bariatric surgeries.
Evaluated the correlation with GLP-1 receptor agonist use.
Identified an increasing trend in the adoption of surgeries correlated with GLP-1 receptor use.
Noted shifts in surgical preference due to medication availability.
Abstract
This cross-sectional analysis examines trends through 2025 in the use of metabolic and bariatric surgery during a period of increasing use of glucagon-like peptide-1 (GLP-1) receptor agonists.